Duchenne Muscular Dystrophy Clinical Trial
Official title:
Motor Learning From Virtual to Natural Environments in Individuals With Duchenne Muscular Dystrophy
With the growing accessibility of computer-assisted technology, one option for rehabilitation programs for individuals with Duchenne muscular dystrophy (DMD) is the use of virtual reality environments to enhance motor practice. Thus, it is important to examine whether performance improvements in the virtual environment generalize to the natural environment. To examine this issue, we had 64 individuals, 32 of which were individuals with DMD and 32 were typically developing individuals. The groups practiced two coincidence timing tasks. In the more tangible button-press task, the individuals were required to 'intercept' a falling virtual object at the moment it reached the interception point by pressing a key on the computer. In the more abstract task, they were instructed to 'intercept' the virtual object by making a hand movement in a virtual environment using a webcam.
The Department of Electronic System Engineering of the Polytechnic School of the University
of São Paulo (Brazil) developed the software that superimposes virtual objects over images
of real world, captured with a webcam.
The coincidence timing task could either have a virtual or a real interface. For the real
interface, a keyboard was used. For the virtual interface, a webcam recorded a marker on the
table alongside the keyboard of the computer. The images were fed into the computer and
analyzed online. Using the custom-made software, it was determined whether or not the
participant's hand occluded the marker, which was then fed back to the virtual environment.
The coincidence timing task was based on the Bassin Anticipation Timer. To this end, 10
3D-cubes were displayed simultaneously in a vertical column on a monitor. The cubes were
turned on (i.e., they changed from white to green) and off sequentially (from top to bottom)
until the target cube (i.e., the tenth cube) was reached. The task for the participant was
to either press the space bar on the keyboard (i.e., tangible button press task, by physical
contact, represented on figure 1A and 1B) or to make a sideward hand gesture as if hitting
the target object (i.e., the more abstract gesture task, with no physical contact,
represented on the figure 1C and 1D), i.e., occluding the marker at the exact moment the
target cube turned green.
Participants performed the task individually in a quiet room with only the examiner who gave
the instructions present. The computer was placed on a table. The participants were seated
in their wheelchair, which was adjusted according to the needs of the individual.
The examiner explained the task verbally and gave three demonstrations of how to perform the
coincidence timing tasks. The participants were instructed to place the preferred hand
(i.e., the less affected hand) on a mark aside to the target (The location was individually
adjusted but ranged from 2 to 4 cm from the target). Once the first top cube turned on, the
individual had to move his hand to either touch the target key on the keyboard or to make a
hitting gesture in front of the webcam, exactly at the moment coinciding with the bottom
target cube turning on. Different sounds were provided as feedback for either a hit or miss
during acquisition, retention and transfer, the range of error being -200 to 200ms.
Participants with DMD and TD were divided into two subgroups randomly: (a) button-press task
group (BPT) - in this group during the acquisition phase the participants should press the
space button on keyboard to complete the coincidence timing task (more real interface) and
(b) gesture task group (GT) - in this group during the acquisition phase the participants
should cross a virtual target created by a webcam to complete the coincidence timing task
instead of press the computer button (more virtual interface).
For all tasks (button-press and gesture), during the acquisition phase, all groups started
performing 20 attempts of the coincidence timing task and, after five minutes with no
contact with the task, they performed five more repetitions for the retention phase (both
phases in slower speed - with the turning on and off of the lights in an interval of 400ms),
finally they performed five repetitions for two different transfers phases: the first
transfer was performed with a faster speed - 300ms of lights interval (transfer with speed
increase - TSI). The second transfer was performed with change task (transfer with exchange
of en vironment - TEE) between groups by doing 5 attempts transfer phase in another
interface. It means, the group that has done the acquisition phase in button-press task
performed the transfer on gesture task and vice versa.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05575648 -
Dual Task in Duchenne Muscular Dystrophy
|
N/A | |
Terminated |
NCT03907072 -
Efficacy and Safety Study of WVE-210201 (Suvodirsen) With Open-label Extension in Ambulatory Patients With Duchenne Muscular Dystrophy
|
Phase 2/Phase 3 | |
Not yet recruiting |
NCT06450639 -
An Open-label Study to Assess the Efficacy and Safety of Satralizumab in Duchenne Muscular Dystrophy
|
Phase 2 | |
Completed |
NCT04335942 -
Characterization of the Postural Habits of Wheelchair Users Analysis of the Acceptability of International Recommendations in the Prevention of Pressure Sores Risk by Using a Connected Textile Sensor
|
N/A | |
Active, not recruiting |
NCT04906460 -
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT02500381 -
Study of SRP-4045 (Casimersen) and SRP-4053 (Golodirsen) in Participants With Duchenne Muscular Dystrophy (DMD)
|
Phase 3 | |
Enrolling by invitation |
NCT05967351 -
A Long-term Follow-up Study of Participants Who Received Delandistrogene Moxeparvovec (SRP-9001) in a Previous Clinical Study
|
Phase 3 | |
Recruiting |
NCT03067831 -
Bone Marrow-Derived Autologous Stem Cells for the Treatment of Duchenne Muscular Dystrophy
|
Phase 1/Phase 2 | |
Recruiting |
NCT01834040 -
Study Safety and Efficacy of BMMNC for the Patient With Duchenne Muscular Dystrophy
|
Phase 1/Phase 2 | |
Completed |
NCT02246478 -
A Study of TAS-205 for Duchenne Muscular Dystrophy
|
Phase 1 | |
Active, not recruiting |
NCT01772043 -
Duchenne Muscular Dystrophy Tissue Bank for Exon Skipping
|
N/A | |
Terminated |
NCT01168908 -
Revatio for Heart Disease in Duchenne Muscular Dystrophy and Becker Muscular Dystrophy
|
Phase 2 | |
Completed |
NCT00758225 -
Long-term Safety, Tolerability and Efficacy of Idebenone in Duchenne Muscular Dystrophy (DELPHI Extension)
|
Phase 2 | |
Completed |
NCT03680365 -
Your Voice; Impact of Duchenne Muscular Dystrophy (DMD) on the Lives of Families
|
||
Recruiting |
NCT03513367 -
The Validation Process for Confirmation of the French Version of the Pediatric Quality of Life Inventory :PedsQLTM.
|
||
Recruiting |
NCT05712447 -
Duchenne Muscular Dystrophy Video Assessment Registry
|
||
Recruiting |
NCT01484678 -
Magnetic Resonance Imaging and Biomarkers for Muscular Dystrophy
|
||
Completed |
NCT03319030 -
Aerobic Exercise in Boys With Duchenne Muscular Dystrophy (DMD)
|
||
Terminated |
NCT01753804 -
A Prospective Natural History Study of Progression of Subjects With Duchenne Muscular Dystrophy.
|
N/A | |
Completed |
NCT02530905 -
Dose-Titration and Open-label Extension Study of SRP-4045 in Advanced Stage Duchenne Muscular Dystrophy (DMD) Patients
|
Phase 1 |